MELISSA BELL: Open Payments
NPI 1851739007 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 32 payments from 7 companies in 2025. Trend: 2023 $311 · 2024 $388 · 2025 $936
Food & beverage: $936
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 10 | $270 |
| Axsome Therapeutics, Inc. | 5 | $225 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $180 |
| Vanda Pharmaceuticals Inc. | 7 | $148 |
| ABBVIE INC. | 4 | $76 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: SPRAVATO, Auvelity, CAPLYTA, FANAPT, VRAYLAR, Qelbree, HETLIOZ, REXULTI.
Industry payments across AR — which companies pay providers there.
